Nerve-derived GDNF increases programmed death ligand 1 (PD-L1) levels in head and neck squamous cell carcinoma cells by activating the JAK2-STAT1 signaling pathway, which in turn promotes the evasion of cancer cells from immune system surveillance in the nerve-cancer microenvironment [73]. Here, STAT1 is linked to cancer.